• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

aTyr Pharma, Inc. - Common Stock (NQ:LIFE)

1.900 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.900
Bid (Size) 1.900 (15)
Ask (Size) 1.950 (20)
Prev. Close 1.900
Today's Range 1.900 - 1.900
52wk Range N/A - N/A
Shares Outstanding 54,291,754
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product
Today 8:01 EST
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution
December 18, 2025
From Ethos Technologies Inc
Via GlobeNewswire

Performance

More News

Read More
News headline image
Ethos Files Registration Statement for Proposed Initial Public Offering
September 26, 2025
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Recap: aTyr Pharma Q4 Earnings ↗
March 14, 2024
Via Benzinga
News headline image
aTyr Pharma's Earnings Outlook ↗
March 13, 2024
Via Benzinga
News headline image
2 Small-Cap Biotech Stocks Well Positioned for a Breakout ↗
August 27, 2025
Via The Motley Fool
News headline image
Ethos and Lifeforce Team Up to Help Policyholders Live Longer, Healthier Lives
August 13, 2025
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
3 Innovation Stocks With Parabolic Upside Potential ↗
August 08, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
1 Small-Cap Biotech Stock Poised for a Breakout ↗
August 06, 2025
Via The Motley Fool
Topics Economy
News headline image
Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors
July 30, 2025
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 ↗
June 05, 2024
Via InvestorPlace
News headline image
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
June 03, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 15, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma to Present at Upcoming Investor Conferences
May 06, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024 ↗
May 02, 2024
Via InvestorPlace
News headline image
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
April 09, 2024
Via Benzinga
News headline image
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition ↗
March 26, 2024
Via InvestorPlace
News headline image
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023 ↗
March 14, 2024
Via InvestorPlace
News headline image
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 14, 2024 ↗
March 14, 2024
Via Benzinga

Frequently Asked Questions

Is aTyr Pharma, Inc. - Common Stock publicly traded?
Yes, aTyr Pharma, Inc. - Common Stock is publicly traded.
What exchange does aTyr Pharma, Inc. - Common Stock trade on?
aTyr Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for aTyr Pharma, Inc. - Common Stock?
The ticker symbol for aTyr Pharma, Inc. - Common Stock is LIFE on the Nasdaq Stock Market
What is the current price of aTyr Pharma, Inc. - Common Stock?
The current price of aTyr Pharma, Inc. - Common Stock is 1.900
When was aTyr Pharma, Inc. - Common Stock last traded?
The last trade of aTyr Pharma, Inc. - Common Stock was at 06/04/24 04:00 PM ET
What is the market capitalization of aTyr Pharma, Inc. - Common Stock?
The market capitalization of aTyr Pharma, Inc. - Common Stock is 103.15M
How many shares of aTyr Pharma, Inc. - Common Stock are outstanding?
aTyr Pharma, Inc. - Common Stock has 103M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap